BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2049502)

  • 1. Repeated confidence intervals for a scale change in a sequential survival study.
    Lin DY; Wei LJ
    Biometrics; 1991 Mar; 47(1):289-94. PubMed ID: 2049502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential monitoring of clinical trials with multiple survival endpoints.
    Williams PL
    Stat Med; 1996 Nov 15-30; 15(21-22):2341-57; discussion 2367-70. PubMed ID: 8931205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exact statistical inference for group sequential trials.
    Lin DY; Wei LJ; DeMets DL
    Biometrics; 1991 Dec; 47(4):1399-408. PubMed ID: 1786325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses.
    Jennison C; Turnbull BW
    Biometrics; 1993 Mar; 49(1):31-43. PubMed ID: 8513110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated confidence intervals for adaptive group sequential trials.
    Mehta CR; Bauer P; Posch M; Brannath W
    Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confidence intervals and sample sizes.
    Grieve AP
    Biometrics; 1991 Dec; 47(4):1597-602; discussion 1602-3. PubMed ID: 1786333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exact, distribution free confidence intervals for late effects in censored matched pairs.
    Daniel SR
    Biom J; 2009 Feb; 51(1):31-44. PubMed ID: 19219909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study duration for clinical trials with survival response and early stopping rule.
    Kim K; Tsiatis AA
    Biometrics; 1990 Mar; 46(1):81-92. PubMed ID: 2350572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of group sequential logrank tests in a maximum duration trial.
    Lan KK; Lachin JM
    Biometrics; 1990 Sep; 46(3):759-70. PubMed ID: 2242413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Planning and monitoring of equivalence studies.
    Durrleman S; Simon R
    Biometrics; 1990 Jun; 46(2):329-36. PubMed ID: 2194579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupled error spending functions for parallel bivariate sequential tests.
    Cook RJ
    Biometrics; 1996 Jun; 52(2):442-50. PubMed ID: 8672698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes.
    Galbraith S; Marschner IC
    Stat Med; 2003 Jun; 22(11):1787-805. PubMed ID: 12754715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group sequential designs for monitoring survival probabilities.
    Lin DY; Shen L; Ying Z; Breslow NE
    Biometrics; 1996 Sep; 52(3):1033-41. PubMed ID: 8805766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential allocation in clinical trials comparing two exponential survival curves.
    Louis TA
    Biometrics; 1977 Dec; 33(4):627-34. PubMed ID: 338043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
    Cheng Y; Shen Y
    Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim treatment selection using the normal approximation approach in clinical trials.
    Shun Z; Lan KK; Soo Y
    Stat Med; 2008 Feb; 27(4):597-618. PubMed ID: 17619239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confidence intervals for the amount of heterogeneity in meta-analysis.
    Viechtbauer W
    Stat Med; 2007 Jan; 26(1):37-52. PubMed ID: 16463355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential designs for clinical trials in amyotrophic lateral sclerosis.
    Groeneveld GJ; van der Tweel I; Wokke JH; van den Berg LH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):202-7. PubMed ID: 15799547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
    Moodie PF; Nelson NA; Koch GG
    Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Under-smoothed kernel confidence intervals for the hazard ratio based on censored data.
    Tu D
    Biom J; 2007 Jun; 49(3):474-83. PubMed ID: 17623350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.